There are certain risk factors associated with colonisation with a Multi Drug Resistant Organism (MDRO).
These include:
- Previous history of having been colonised with the organism
- Recent inpatient stay in a Healthcare facility
- Residents in Long term care facilities and nursing homes
- Patients who have received recurrent courses of certain antibiotics (Vancomycin in the case of VRE as an example)
There are other patient related risks associated with increased susceptibility to infectious diseases such as:
While laboratory systems provide data on core numbers of these infections and some provide the location of each patient, the need to collect data on source of infection and whether or not isolation precautions are in place is essentially a manual task.
Laboratory systems also don’t report the patients who are ‘at risk’ – the hospital transfers and those with colonisation history in other healthcare settings.
Medical Audits have developed an audit tool specifically to support Infection prevention and control nurses (IPCN) during daily ward rounds. Using our system will assist in data collection and analysis of route of admission, transmission of infection and monitor availability of isolation rooms.
Surveillance of an alert organism/MDRO is so easy when you use Medical Audits Surveillance System
✔ You can audit and generate reports relating to colonisation and infection with Methicillin Resistant Staphylococcus Aureus (MRSA), Vancomycin Resistant Enterococci (VRE), Carbapenem Resistant Enterobacteriaceae (CRE), Clostridioides difficile (formally known as Clostridium difficile, C. Diff.), Tuberculosis (TB) etc.
✔ Check patients isolated and track source of infection.
✔ Monitor at risk patients prior to diagnosis.
✔ Record source of admission of colonised and infected patients.
Preadmission Screening is the Gold Standard in Controlling Spread of MRSA and other Multi Drug resistant Organisms (MDROs)
- The patient can receive treatment in advance of hospital admission or if this isn’t possible, the healthcare facility can at least know in advance and have a single room available for the patient if required.
- In the case of MRSA for example research indicates that patients colonised with MRSA acquired an infection 3% of patients colonised with MRSA on admission to hospital will develop an MRSA infection compared to 0.1% of those MRSA negative on admission (HPS, 2009.
Part of the role of IPCNs is to check with staff in the department if there are any patients with possible infectious diseases, ensuring they are isolated if needed
Ideally every patient who is colonised or infected with a multi drug resistant organism should be isolated in a single room with ensuite facilities.
When single rooms are in short supply a recognised scoring method such as the Lewisham model for accessing infectious risk can be used.
Medical Audits multi drug resistant organism Surveillance System Facilitates Monitoring of Isolation Room Usage
- Using medical audits Infection Prevention audit tool you can quickly and efficiently. monitor your usage of isolation rooms and track patients requiring transmission based precautions and isolation.
- Medical Audits develop our systems with reference to National standards for Infection prevention across the EU and the UK.
- You can audit against all the newest standards and be confident you will identify issues quickly and efficiently.